These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Carcinoid syndrome due to pancreatic-duct neoplasm secreting 5-hydroxytryptophan and 5-hydroxytryptamine. PEART WS; PORTER KA; ROBERTSON JI; SANDLER M; BALDOCK E Lancet; 1963 Feb; 1(7275):239-43. PubMed ID: 13942269 [No Abstract] [Full Text] [Related]
6. A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoids. OATES JA; SJOERDSMA A Am J Med; 1962 Mar; 32():333-42. PubMed ID: 14480945 [No Abstract] [Full Text] [Related]
7. Biochemical effect of phenylacetic acid in a patient with 5-hydroxytryptophan-secreting carcinoid tumor. SANDLER M; CLOSE HG Lancet; 1959 Sep; 2(7098):316-8. PubMed ID: 14441431 [No Abstract] [Full Text] [Related]
8. Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan. SJOERDSMA A; OATES JA; ZALTZMAN P; UDENFRIEND S N Engl J Med; 1960 Sep; 263():585-8. PubMed ID: 13831424 [No Abstract] [Full Text] [Related]
9. 5-Hydroxytryptophan as an intermediate of serotonin biosyntheses in malignant carcinoidosis. DONALDSON RM; GRAY SJ; LETSOU VG Lancet; 1959 Dec; 2(7110):1002-3. PubMed ID: 13817482 [No Abstract] [Full Text] [Related]
10. [Carcinoid and carcinoid syndrome]. Porst H; Naas W; Renger F; Dökert B; Platzbecker H Z Gesamte Inn Med; 1974 Aug; 29(15):635-8. PubMed ID: 4549154 [No Abstract] [Full Text] [Related]
11. [The carcinoid syndrome]. Laplante L; Archambault A; Thibert F Union Med Can; 1971 Oct; 100(10):1970-84. PubMed ID: 5316830 [No Abstract] [Full Text] [Related]
12. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. Feldman JM Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417 [TBL] [Abstract][Full Text] [Related]
13. Biochemical assessment of niacin deficiency among carcinoid cancer patients. Shah GM; Shah RG; Veillette H; Kirkland JB; Pasieka JL; Warner RR Am J Gastroenterol; 2005 Oct; 100(10):2307-14. PubMed ID: 16181385 [TBL] [Abstract][Full Text] [Related]
14. Urinary free cortisol excretion in patients with hyperserotoninaemia from the carcinoid syndrome. Feldman JM Clin Endocrinol (Oxf); 1979 Nov; 11(5):541-8. PubMed ID: 316372 [TBL] [Abstract][Full Text] [Related]
16. [CURRENT DATA ON BIOCHEMISTRY OF THE CARCINOID SYNDROME]. LEMONNIER A; CHARPENTIER C; LEMONNIER F Rev Med Chir Mal Foie; 1965 Feb; 40():18-26. PubMed ID: 14309257 [No Abstract] [Full Text] [Related]
17. [Current views on carcinoid and the carcinoid syndrome]. Ryss ES Klin Med (Mosk); 1971 Jan; 49(1):13-9. PubMed ID: 4396993 [No Abstract] [Full Text] [Related]
18. [Laboratory findings in the carcinoid syndrome]. Kähler HJ Dtsch Med Wochenschr; 1968 May; 93(19):959-61. PubMed ID: 5300909 [No Abstract] [Full Text] [Related]
19. Malignant carcinoid tumor altered reactivity of the skin to serotonin in two patients. ROTBART M Calif Med; 1958 Feb; 88(2):112-3. PubMed ID: 13500214 [TBL] [Abstract][Full Text] [Related]